World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
54
Citations
13554
World Ranking
3921
National Ranking
1526

Overview

Richard C. Reichman is affiliated with the University of Rochester in the United States. Their research primarily focuses on the fields of Medicine and Immunology and Microbiology, with subfields concentrated on Infectious Diseases and Virology.

The scientist's work encompasses topics related to HIV/AIDS, including drug development, treatment, research, and interventions in this area.

Recent scholarly contributions include a paper titled "Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection," published in 2021 in the UNC Libraries venue.

  • Roy M. Gulick
  • Heather J. Ribaudo
  • Cecilia M. Shikuma
  • Stephanie Lustgarten
  • Kathleen Squires

  • UNC Libraries (1 publication)

The research output consists of multiple publications addressing HIV/AIDS drug development and treatment strategies within infectious disease contexts.

Best Publications

  • Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection: A Controlled Trial in Persons with Fewer Than 500 CD4-Positive Cells per Cubic Millimeter

    Paul A. Volberding;Stephen W. Lagakos;Matthew A. Koch;David K. Booth

  • Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group.

    Ann C. Collier;Robert W. Coombs;David A. Schoenfeld;Roland L. Bassett

  • Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection

    Roy M. Gulick;Roy M. Gulick;Heather J. Ribaudo;Cecilia M. Shikuma;Stephanie Lustgarten

  • A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection

    R Dolin;R C Reichman;H P Madore;R Maynard

  • The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter

    David A. Katzenstein;Scott M. Hammer;Michael D. Hughes;Holly Gundacker

  • Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles.

    R C Rose;W Bonnez;R C Reichman;R L Garcea

  • A Randomized Controlled Trial of a Reduced Daily Dose of Zidovudine in Patients with the Acquired Immunodeficiency Syndrome

    Margaret A. Fischl;Corette B. Parker;Carla Pettinelli;Michael Wulfsohn

  • Treatment of Recurrent Genital Herpes Simplex Infections With Oral Acyclovir: A Controlled Trial

    R C Reichman;G J Badger;G J Mertz;L Corey

  • Herpes Zoster-Varicella Infections in Immunosuppressed Patients

    Raphael Dolin;Richard C. Reichman;Mark H. Mazur;Richard J. Whitley

  • Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211.

    Roy M. Gulick;Zhaohui Su;Charles Flexner;Michael D. Hughes

  • Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.

    Roy M. Gulick;Heather J. Ribaudo;Cecilia M. Shikuma;Christina Lalama

  • Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. OFF.

    S C Dollard;J L Wilson;L M Demeter;W Bonnez

  • A Phase 1 Study of a Recombinant Viruslike Particle Vaccine against Human Papillomavirus Type 11 in Healthy Adult Volunteers

    Thomas G. Evans;William Bonnez;Robert C. Rose;Scott Koenig

  • Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection.

    Gregory J. Mertz;Cathy W. Critchlow;Jacqueline Benedetti;Richard C. Reichman

  • Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantaris.

    J. Corwin Vance;Bruce J. Bart;Ronald C. Hansen;Richard C. Reichman

  • Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera

    Robert C. Rose;Richard C. Reichman;William Bonnez

  • Mechanisms for the Deterioration in Glucose Tolerance Associated With HIV Protease Inhibitor Regimens

    Hans J. Woerle;Peter R. Mariuz;Christian Meyer;Richard C. Reichman

  • APOBEC3G/CEM15 (hA3G) mRNA Levels Associate Inversely with Human Immunodeficiency Virus Viremia

    Xia Jin;Andy Brooks;Huiyuan Chen;Ryan Bennett

  • The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.

    Paul A. Volberding;Stephen W. Lagakos;Janet M. Grimes;Daniel S. Stein

  • Antiviral Activity of Single-Dose PRO 140, a CCR5 Monoclonal Antibody, in HIV-Infected Adults

    Jeffrey M. Jacobson;Michael S. Saag;Melanie A. Thompson;Margaret A. Fischl

  • Serological differentiation of human papillomavirus types 11, 16 and 18 using recombinant virus-like particles.

    R C Rose;W Bonnez;C Da Rin;D J McCance

Frequent Co-Authors

Raphael Dolin
Raphael Dolin Beth Israel Deaconess Medical Center
Margaret A. Fischl
Margaret A. Fischl University of Miami
Douglas D. Richman
Douglas D. Richman University of California, San Diego
Alan Forrest
Alan Forrest University at Buffalo, State University of New York
Mark H. Stoler
Mark H. Stoler University of Virginia
Richard J. Whitley
Richard J. Whitley University of Alabama at Birmingham
Thomas C. Merigan
Thomas C. Merigan Stanford University
Martin S. Hirsch
Martin S. Hirsch Harvard Medical School
William G. Powderly
William G. Powderly Washington University in St. Louis
Roy M. Gulick
Roy M. Gulick Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open diverse career opportunities. Programs like the fastest and easiest online MPH programs provide a pathway into public health, complementing microbiology knowledge with practical skills in disease prevention and health promotion.

Career options extend beyond traditional lab roles. For instance, becoming a child life specialist salary reflects the demand for professionals supporting children’s emotional and developmental needs in healthcare settings. This role benefits from a background in biological sciences, including microbiology.

Individuals with unique challenges, such as those looking for the best degree for felons, can also find suitable online programs that align with scientific careers. Many institutions now offer accessible options to help rebuild careers legally and responsibly.

Additionally, careers like a functional medicine nurse practitioner can be very rewarding. Exploring the functional medicine nurse salary highlights the financial viability and growing relevance of holistic health roles intertwined with microbiological expertise.

Best Scientists Citing Richard C. Reichman

Trending Scientists